In a new study in Nature Neuroscience, researchers at the Mount Sinai School of Medicine show that the reason some people with schizophrenia don't respond to antipsychotic drugs is because of the way the drugs affect DNA structure, reports Ed Yong at The Scientist.
...and receive Daily News bulletins.
Already have an account?Login Now.
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.